LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Neumora Therapeutics (NASDAQ: NMRA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ NMRA Neumora Therapeutics
Lenz Robert A. / officer: Head of R&D
10/09/2024
Sell
$15.01
5,563
$84K
322,966
NASDAQ NMRA Neumora Therapeutics
Lenz Robert A. / officer: Head of R&D
10/10/2024
Sell
$15.09
8,260
$125K
314,706
NASDAQ NMRA Neumora Therapeutics
Lenz Robert A. / officer: Head of R&D
09/17/2024
Sell
$11.81
30,788
$364K
339,205
NASDAQ NMRA Neumora Therapeutics
Lenz Robert A. / officer: Head of R&D
09/18/2024
Sell
$12.09
10,676
$129K
328,529
NASDAQ NMRA Neumora Therapeutics
Lenz Robert A. / officer: Head of R&D
09/12/2024
Sell
$11.43
32,948
$377K
369,993
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Sell
$6.51
136,210
$887K
207,901
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Buy
$4.24
137,538
$583K
137,538
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Buy
$6.51
136,210
$887K
136,210
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Sell
$6.36
29,737
$189K
72,221
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Sell
$4.24
137,538
$583K
40,890
NASDAQ NMRA Neumora Therapeutics
Aurora Daljit Singh / officer: Chief Strategy Officer
09/12/2024
Buy
$6.36
29,737
$189K
29,737

COPYRIGHT ©2023 HEALTH STOCKS HUB